Skip to content
  • About Us
  • Science
  • Pipeline
  • News
  • Careers
  • Contact Us
  • Video Overview
Menu
  • About Us
  • Science
  • Pipeline
  • News
  • Careers
  • Contact Us
  • Video Overview

A $6 million seed round led by 4BIO Capital will help startup Ray Therapeutics advance optogenetic therapy Ray-001 into the clinic for retinitis pigmentosa.

©Ray Therapeutics. All rights reserved | Site by BKW